Open original FDA record ↗Recall record
- FDA identifier
- Z-0846-2012
- Company in FDA record
- Lin-Zhi International Inc
- FDA classification date
- Jan 24, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Catalog #0140 and 0141 Barbiturate EIA small and large kits were not correctly made to specification such that the two antibodies used in production did not have curves that correctly aligned.
Source facts
- Action
- Lin-Zhi sent a letter via e-mail dated September 8, 2011 to customers with information regarding the recall. The e-mail identified the product description, lot number, description of nonconformity and corrective actions to be taken. Each customer and distributor was then contacted by regulatory affairs personnel by phone on September 9, 2011 or September 12, 2011. Customers and distributors were contacted to determined whether they wanted a replacement of the affected product. Customers that wished for replacements of the affected product was asked to correctly dispose of the product with the lot numbers listed. For questions or concern call 408-732-3856.
- Initiated
- 2011-09-08
- Root cause
- Nonconforming Material/Component
- Terminated
- 2012-01-25
- Distribution
- Worldwide Distribution - USA (nationwide) including the states of: AL, CA, FL, IN, MA, NC, NH, TX and the countries of: Germany and United Kingdom.
- Recall number
- Z-0846-2012
- Recall status
- Terminated
- CDRH record ID
- 106392
- FDA classified
- 2012-01-24
- Recall event number
- 60750